Stryker Corporation (SYK) Stock

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Stryker Corporation is led by CEO Kevin A. Lobo, employs 53,000 people, headquartered in Portage, US, publicly traded since 1980.

Stryker Corporation (SYK) stock trades at $352.25 with a market capitalization of $135.04B. The stock is valued at a price-to-earnings (P/E) ratio of 33.00, price-to-book of 4.87, price-to-sales of 4.71. Over the past 52 weeks the stock has ranged between $304.64 and $404.87, and currently trades 13.0% below its 52-week high. It pays a dividend yielding 1.11%.

On profitability, Stryker Corporation generates a return on equity (ROE) of 15.20%, above the typical market average, return on capital employed of 21.81%, an operating margin of 19.47%, a net profit margin of 13.21%.

In its most recent fiscal year, Stryker Corporation reported annual revenue of $25.1B, net profit of $3.2B, revenue has compounded at 11.8% a year over the last five years, profit at 15.2% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.66, a current ratio of 1.89, total assets of $47.8B, $4.0B in cash and equivalents.

SYK has an average daily trading volume of 2,782,567 shares, a beta of 0.79 (less volatile than the overall market).

Official website: www.stryker.com